108 related articles for article (PubMed ID: 32938954)
21. Derivatives of alkyl gallate triphenylphosphonium exhibit antitumor activity in a syngeneic murine model of mammary adenocarcinoma.
Peredo-Silva L; Fuentes-Retamal S; Sandoval-Acuña C; Pavani M; Maya JD; Castro-Castillo V; Madrid-Rojas M; Rebolledo S; Kemmerling U; Parra E; Ferreira J
Toxicol Appl Pharmacol; 2017 Aug; 329():334-346. PubMed ID: 28647477
[TBL] [Abstract][Full Text] [Related]
22. Simultaneous targeting of XPO1 and BCL2 as an effective treatment strategy for double-hit lymphoma.
Liu Y; Azizian NG; Dou Y; Pham LV; Li Y
J Hematol Oncol; 2019 Nov; 12(1):119. PubMed ID: 31752970
[TBL] [Abstract][Full Text] [Related]
23. Toxicity and antineoplastic effect of (24R)-1,24-dihydroxyvitamin D3 (PRI-2191).
Wietrzyk J; Pełczyńska M; Madej J; Dzimira S; Kuśnierczyk H; Kutner A; Szelejewski W; Opolski A
Steroids; 2004 Sep; 69(10):629-35. PubMed ID: 15465107
[TBL] [Abstract][Full Text] [Related]
24. 1,1-Bis(3'-indolyl)-1-(p-biphenyl)methane inhibits basal-like breast cancer growth in athymic nude mice.
Su Y; Vanderlaag K; Ireland C; Ortiz J; Grage H; Safe S; Frankel AE
Breast Cancer Res; 2007; 9(4):R56. PubMed ID: 17764562
[TBL] [Abstract][Full Text] [Related]
25. Efficacy of a novel orally active SERD AZD9496 against hormone dependent post-menopausal breast cancer depends on inhibition of cellular aromatase activity.
Kazi A; Goloubeva O; Schech A; Yu S; Sabnis GJ
J Steroid Biochem Mol Biol; 2020 Sep; 202():105697. PubMed ID: 32461092
[TBL] [Abstract][Full Text] [Related]
26. Preliminary evaluation of in vitro cytotoxicity and in vivo antitumor activity of Premna herbacea Roxb. in Ehrlich ascites carcinoma model and Dalton's lymphoma ascites model.
Dhamija I; Kumar N; Manjula SN; Parihar V; Setty MM; Pai KS
Exp Toxicol Pathol; 2013 Mar; 65(3):235-42. PubMed ID: 21920724
[TBL] [Abstract][Full Text] [Related]
27. Indole-coumarin-thiadiazole hybrids: An appraisal of their MCF-7 cell growth inhibition, apoptotic, antimetastatic and computational Bcl-2 binding potential.
Kamath PR; Sunil D; Joseph MM; Abdul Salam AA; T T S
Eur J Med Chem; 2017 Aug; 136():442-451. PubMed ID: 28525842
[TBL] [Abstract][Full Text] [Related]
28. Inhibitory effect of Abrus abrin-derived peptide fraction against Dalton's lymphoma ascites model.
Bhutia SK; Mallick SK; Maiti S; Maiti TK
Phytomedicine; 2009 Apr; 16(4):377-85. PubMed ID: 18706794
[TBL] [Abstract][Full Text] [Related]
29. Antitumor, hematostimulative and radioprotective action of water-soluble derivative of propolis (WSDP).
Orsolić N; Basić I
Biomed Pharmacother; 2005 Dec; 59(10):561-70. PubMed ID: 16202559
[TBL] [Abstract][Full Text] [Related]
30. Downregulation of STAT3 phosphorylation enhances tumoricidal effect of IL-15-activated dendritic cell against doxorubicin-resistant lymphoma and leukemia via TNF-α.
Hira SK; Mondal I; Bhattacharya D; Gupta KK; Manna PP
Int J Biochem Cell Biol; 2015 Oct; 67():1-13. PubMed ID: 26255115
[TBL] [Abstract][Full Text] [Related]
31. Novel hybrid molecule overcomes the limited response of solid tumours to HDAC inhibitors via suppressing JAK1-STAT3-BCL2 signalling.
Huang Z; Zhou W; Li Y; Cao M; Wang T; Ma Y; Guo Q; Wang X; Zhang C; Zhang C; Shen W; Liu Y; Chen Y; Zheng J; Yang S; Fan Y; Xiang R
Theranostics; 2018; 8(18):4995-5011. PubMed ID: 30429882
[TBL] [Abstract][Full Text] [Related]
32. Preclinical studies of TW-37, a new nonpeptidic small-molecule inhibitor of Bcl-2, in diffuse large cell lymphoma xenograft model reveal drug action on both Bcl-2 and Mcl-1.
Mohammad RM; Goustin AS; Aboukameel A; Chen B; Banerjee S; Wang G; Nikolovska-Coleska Z; Wang S; Al-Katib A
Clin Cancer Res; 2007 Apr; 13(7):2226-35. PubMed ID: 17404107
[TBL] [Abstract][Full Text] [Related]
33. Proapoptotic and antitumor activities of the HMG-CoA reductase inhibitor, lovastatin, against Dalton's lymphoma ascites tumor in mice.
Ajith TA; Harikumar KB; Thasna H; Sabu MC; Babitha NV
Clin Chim Acta; 2006 Apr; 366(1-2):322-8. PubMed ID: 16380106
[TBL] [Abstract][Full Text] [Related]
34. A Novel MCL1 Inhibitor Combined with Venetoclax Rescues Venetoclax-Resistant Acute Myelogenous Leukemia.
Ramsey HE; Fischer MA; Lee T; Gorska AE; Arrate MP; Fuller L; Boyd KL; Strickland SA; Sensintaffar J; Hogdal LJ; Ayers GD; Olejniczak ET; Fesik SW; Savona MR
Cancer Discov; 2018 Dec; 8(12):1566-1581. PubMed ID: 30185627
[TBL] [Abstract][Full Text] [Related]
35. Amelioration of Dalton's lymphoma-induced angiogenesis by melatonin.
Kumari R; Rawat K; Kumari A; Shrivastava A
Tumour Biol; 2017 Jun; 39(6):1010428317705758. PubMed ID: 28618962
[TBL] [Abstract][Full Text] [Related]
36. Small-molecule inhibitors of Bcl-2 family proteins are able to induce tumor regression in a mouse model of pre-B-cell acute lymphocytic lymphoma.
Turner BC; Eves T; Refaeli Y
DNA Cell Biol; 2008 Mar; 27(3):133-42. PubMed ID: 18163880
[TBL] [Abstract][Full Text] [Related]
37. Curcumin-albumin conjugates as an effective anti-cancer agent with immunomodulatory properties.
Aravind SR; Krishnan LK
Int Immunopharmacol; 2016 May; 34():78-85. PubMed ID: 26927614
[TBL] [Abstract][Full Text] [Related]
38. Targeting BCL2 in Chronic Lymphocytic Leukemia and Other Hematologic Malignancies.
Yalniz FF; Wierda WG
Drugs; 2019 Aug; 79(12):1287-1304. PubMed ID: 31313099
[TBL] [Abstract][Full Text] [Related]
39. Therapeutic efficacy and molecular mechanisms of snake (Walterinnesia aegyptia) venom-loaded silica nanoparticles in the treatment of breast cancer- and prostate cancer-bearing experimental mouse models.
Badr G; Al-Sadoon MK; Rabah DM
Free Radic Biol Med; 2013 Dec; 65():175-189. PubMed ID: 23811005
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of peritoneal dissemination of ovarian cancer by tyrosine kinase receptor inhibitor SU6668 (TSU-68).
Machida S; Saga Y; Takei Y; Mizuno I; Takayama T; Kohno T; Konno R; Ohwada M; Suzuki M
Int J Cancer; 2005 Mar; 114(2):224-9. PubMed ID: 15551349
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]